Thymulin
Also known as: FTS, Facteur Thymique Serique, Thymic Factor, Serum Thymic Factor
Grey-Market Compound. This compound is not approved by the FDA or any major regulatory authority. No established regimen exists. Products available outside of regulated channels lack standardized manufacturing, quality control, and potency verification. Consult a qualified clinician. Research-only risks apply.
Overview
Clinical Summary
Thymulin (also known as FTS, facteur thymique serique) is a nonapeptide hormone produced by thymic epithelial cells. It requires zinc for biological activity, forming a zinc-thymulin complex that is the active circulating form. Thymulin promotes T-cell differentiation and maturation, modulates cytokine production, and supports immune surveillance. Serum thymulin levels decline significantly with age, paralleling thymic involution, and this decline has been linked to age-related immune dysfunction (immunosenescence). Interest in thymulin for aging immune reconstitution has grown, though clinical data remain limited.
Plain Language Summary
Thymulin is a natural hormone produced by your thymus gland that helps train and mature immune cells (T-cells). As you age, your thymus shrinks and thymulin levels drop dramatically, which may partly explain why older people have weaker immune systems. Researchers are exploring whether supplementing thymulin could help restore immune function in aging. The evidence so far is mostly from animal studies, and it is available only through grey-market sources.
Mechanism of Action
Thymulin is a nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) that requires a zinc ion (Zn2+) bound in a 1:1 stoichiometric complex to achieve biological activity. The zinc-thymulin complex binds to high-affinity receptors on T-cell precursors and mature T-cells. Its biological effects include: induction of T-cell differentiation markers (CD2, CD3, CD4, CD8), enhancement of T-cell cytotoxicity, modulation of cytokine release (suppression of IL-1 and TNF-alpha, enhancement of IL-2), and support of regulatory T-cell function. Thymulin also has analgesic and anti-inflammatory properties mediated through the hypothalamic-pituitary-adrenal axis.
Evidence Summary
Dardenne et al. (1984) characterized thymulin and demonstrated its role in T-cell maturation and zinc-dependent activation. Animal studies have shown that thymulin gene therapy can restore immune function and reduce inflammation in aged mice (Reggiani et al., 2014). Human studies have established that serum thymulin declines with age and correlates with immune decline. Limited clinical data from small studies in the 1980s and 1990s suggested immune-enhancing effects, but no modern RCTs have been conducted. Zinc supplementation alone can partially restore thymulin activity in zinc-deficient elderly individuals.
Safety Profile
Thymulin has been used in limited clinical settings with a generally favorable safety profile. As an endogenous hormone, it is expected to be well tolerated. Zinc status must be adequate for thymulin to function, and zinc supplementation may be required concurrently. Excessive immune stimulation is a theoretical concern in autoimmune conditions. No formal toxicology studies of exogenous thymulin have been published in modern literature.
Contraindications
- Known hypersensitivity to thymic peptides
- Active autoimmune disease (theoretical risk of immune overstimulation)
- Zinc overload conditions (Wilson disease)
- Pregnancy and breastfeeding (no safety data)
Adverse Events
- Injection site reactions (mild)
- Theoretical risk of autoimmune exacerbation
- Zinc-related GI discomfort if co-supplemented
- Limited adverse event data from published literature
Interactions
- Zinc supplements may enhance thymulin activity (required cofactor)
- Immunosuppressive medications may counteract thymulin effects
- Chelating agents may inactivate thymulin by removing zinc
Regulatory Notes
Thymulin has no current regulatory approval in any jurisdiction as a standalone therapeutic agent. It was studied in limited clinical settings in the 1980s and 1990s. Available through grey-market peptide vendors. Zinc-thymulin combination products are marketed in some anti-aging clinics.
Monitoring Considerations
Serum zinc levels should be assessed before and during thymulin use. T-cell subset analysis (CD4, CD8, CD4/CD8 ratio) may be used to assess immune response. Inflammatory markers (CRP, ESR). Monitor for signs of autoimmune activation in susceptible individuals.
These are general considerations for clinical awareness and do not constitute prescriptive monitoring recommendations for any individual patient.
Stability and Handling Notes
Grey-market preparations are supplied as lyophilized powder. Zinc must be present for biological activity. Store lyophilized at minus 20 degrees C or 2 to 8 degrees C. Reconstitute with bacteriostatic water. The zinc-peptide complex may dissociate in solution over time. No pharmacopeial stability standards exist.
References
- 1review
Thymulin (Facteur Thymique Serique): A Thymic Hormone with Immunomodulatory Properties
Dardenne M, Savino W, Bach JF. (1984). Progress in Clinical and Biological Research
Key findings: Characterization of thymulin as a zinc-dependent nonapeptide produced by thymic epithelial cells. Promotes T-cell differentiation and maturation, modulates cytokine production, and declines with age in parallel with thymic involution.
Limitations: Early characterization work. Limited clinical trial data. Most findings from animal and in vitro studies.
- 2preclinical
Thymulin Gene Therapy Restores Immune Function and Reduces Inflammation in Aging Mice
Reggiani PC, Morel GR, Console GM, et al. (2014). Experimental Gerontology
Key findings: Thymulin gene therapy in aging mice restored thymulin serum levels, improved T-cell function, reduced inflammatory markers, and partially reversed age-related immune decline.
Limitations: Murine model. Gene therapy delivery rather than peptide administration. Not directly translatable to peptide injection protocols.
View source
Last reviewed: 2026-03-24 | Version: 1 | Status: Published
More in Longevity/Immune
Thymosin Alpha-1
Ta1 · Thymalfasin · Zadaxin
Thymosin alpha-1 is a peptide naturally produced by your thymus gland, which is important for immune function. A synthetic version called Zadaxin is approved in many countries around the world (but not the US) for treating hepatitis B and boosting the immune system. It is one of the most well-studied peptides available, with thousands of published research papers. Some people use it for general immune support and longevity purposes.
Epitalon
Epithalon · Epithalone · AGAG · Ala-Glu-Asp-Gly
Epitalon is a small lab-made peptide based on a substance from the pineal gland, studied primarily by Russian researchers for anti-aging purposes. The claim is that it can activate telomerase, an enzyme that helps maintain the protective caps (telomeres) on your chromosomes, potentially slowing aging. The evidence for these claims is very limited, and it is not approved anywhere as a medication. It is one of the more speculative peptides available in the grey market.
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c
MOTS-c is a naturally occurring peptide produced by your mitochondria (the energy factories in your cells). It acts like an exercise signal, helping your body use sugar more efficiently and improving insulin sensitivity. Levels of MOTS-c naturally decrease as you age. A small human study showed that daily injections improved how the body handles insulin in obese men. It is still very early in research and is only available through grey-market sources.
Want to discuss this compound with a qualified physician?
The Peptide Association has verified over 160 licensed providers specializing in peptide therapy, with telehealth options available in most states.
Find a Verified Provider